GlassScriptPhysician profile
Jacob T Straley
NPI 1366957060
$1,693.54
in general payments reported to CMS, 2019-2025
15 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $330 · 2023: $398 · 2024: $353 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $903.52 | 2021-2025 | Puraply, Affinity, Apligraf |
| Smith+Nephew, INC. | $169.64 | 2023-2025 | Collagenase Santyl, Pico, Renasys Touch |
| Inari Medical, INC. | $143.87 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $96.62 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Abbvie INC. | $92.51 | 2024-2025 | |
| Mimedx Group, INC. | $73.97 | 2024-2025 | |
| Kci USA, INC. | $44.63 | 2021-2022 | |
| Solventum Corporation | $33.60 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Integra Lifesciences Corporation | $27.88 | 2023-2025 | Tcc-Ez |
| Paratek Pharmaceuticals, INC. | $23.52 | 2023 | Nuzyra |
| Medela LLC | $19.96 | 2022 | |
| Hartmann USA, INC. | $19.24 | 2021 | |
| Urgo Medical North America, LLC | $16.82 | 2024 | Urgoclean Ag |
| Convatec INC. | $14.27 | 2023 | |
| Melinta Therapeutics, LLC | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Straley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.